AlphaMark Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $22K | Hold |
342
| – | – | 0.01% | 341 |
|
|
2024
Q3 | $27K | Sell |
342
-50
| -13% | -$3.95K | 0.01% | 392 |
|
|
2024
Q2 | $31K | Hold |
392
| – | – | 0.01% | 392 |
|
|
2024
Q1 | $27K | Hold |
392
| – | – | 0.01% | 410 |
|
|
2023
Q4 | $26K | Hold |
392
| – | – | 0.01% | 416 |
|
|
2023
Q3 | $27K | Sell |
392
-120
| -23% | -$8.27K | 0.01% | 391 |
|
|
2023
Q2 | $37K | Hold |
512
| – | – | 0.02% | 249 |
|
|
2023
Q1 | $36K | Hold |
512
| – | – | 0.02% | 261 |
|
|
2022
Q4 | $35K | Sell |
512
-6
| -1% | -$410 | 0.02% | 237 |
|
|
2022
Q3 | $28K | Hold |
518
| – | – | 0.01% | 267 |
|
|
2022
Q2 | $34K | Hold |
518
| – | – | 0.02% | 257 |
|
|
2022
Q1 | $34K | Hold |
518
| – | – | 0.01% | 269 |
|
|
2021
Q4 | $30K | Buy |
518
+6
| +1% | +$347 | 0.01% | 286 |
|
|
2021
Q3 | $31K | Buy |
512
+292
| +133% | +$17.7K | 0.01% | 276 |
|
|
2021
Q2 | $13K | Hold |
220
| – | – | ﹤0.01% | 372 |
|
|
2021
Q1 | $11K | Buy |
220
+100
| +83% | +$5K | ﹤0.01% | 378 |
|
|
2020
Q4 | $6K | Hold |
120
| – | – | ﹤0.01% | 404 |
|
|
2020
Q3 | $7K | Buy |
+120
| New | +$7K | ﹤0.01% | 395 |
|